
    
      A double-blind, placebo-controlled study where healthy adult subjects will be randomly
      assigned to receive either of the investigational products (Zidebactam or placebo) in 2
      multiple ascending dose (MAD) cohorts.

      Primary Objective: to evaluate the safety and tolerability of multiple escalating doses of
      intravenous (IV) zidebactam in healthy adult human subjects.

      Secondary Objective: to evaluate the pharmacokinetics (PK) of multiple escalating doses of IV
      zidebactam in healthy adult human subjects.
    
  